10 free AEMT practice questions: Medication Administration Routes

A pain medication given through a transdermal patch: A patch looks like the least invasive thing on the list, which makes it feel like the safe answer. Transdermal is one of the routes the national model holds at the Paramedic level, so applying it is a scope violation rather than a judgment call.

A sedative instilled through a nasogastric tube: The tube is already in place, so using it seems like it costs nothing. Nasogastric is also a Paramedic-level route, and an existing tube does not move a route into your column.

An antipyretic given by the rectal route: Rectal administration feels like basic nursing care rather than an advanced skill. It is on the reserved list too, alongside the patch and the tube, so it is out for the same reason.

Right dose: Dose errors are the ones that get feared most, so this is the reflex answer. The amount drawn up is not the problem here; the problem is where the label says the drug may go.

Right time: Timing matters when a repeat dose is due, which makes this sound relevant. Nothing in this scene is about when to give the drug, only about how it is allowed to be given.

Right documentation: Documentation is a right, and it is the one people forget. Documenting happens after the drug is given, so it cannot catch a label mismatch beforehand.

Analgesia, antiemetic, dextrose, epinephrine, glucagon, and amiodarone: Amiodarone shows up in every arrest algorithm, so it feels like it must be on the list somewhere. Antiarrhythmics stay at the Paramedic level, so amiodarone is not on the AEMT list by any route.

Analgesia, antiemetic, dextrose, epinephrine, lidocaine, and naloxone: Lidocaine is the other familiar arrest antiarrhythmic, and swapping it in looks harmless. It sits on the Paramedic side of the same boundary, and taking naloxone off the list to make room removes one of the six that is genuinely there.

Analgesia, antiemetic, dextrose, midazolam, glucagon, and naloxone: A benzodiazepine is carried by plenty of AEMT services, so seeing one here looks right. No general sedative or anticonvulsant is on the national list, and where a service carries one it arrived through a state or local protocol rather than the national floor.

Swallowed whole with a full glass of water: Swallowing a tablet whole with water is how most people take medication, so it reads as normal and safe. Whole tablets have to break down in the stomach first, and that delay is the exact thing chewing removes.

Dissolved under the tongue and held there: Holding a tablet under the tongue borrows the sublingual route, which really is fast for the right drug. Aspirin is not formulated for that route, and treating it as sublingual does not speed it up.

Crushed and stirred into a spoonful of food: Mixing a crushed tablet into food is a real trick for patients who struggle with pills. Food slows gastric emptying, so the dose ends up reaching the circulation later rather than sooner.

Four 81 mg chewable tablets, the full target dose: Four tablets is the dose you give when no aspirin is on board, reaching 324 mg from zero. The patient already took 81 mg two hours ago, so four more tablets pushes the total to 405 mg, past the 324 mg target instead of landing on it.

A single 325 mg tablet, since the earlier dose has worn off: A single 325 mg tablet fits the reasoning that aspirin's effect fades with time, since plasma levels drop within hours. Platelet cyclooxygenase-1 stays acetylated for that platelet's whole life, so the 81 mg from two hours ago still counts, and 325 mg on top overshoots the 324 mg target.

Two 81 mg chewable tablets, half of the target dose: Two tablets feels like a cautious half measure after a dose already given. That's 162 mg added to the 81 mg on board, 243 mg total, 81 mg short of the 324 mg target the protocol sets, leaving the patient undertreated.

Fat holds a larger volume, so the dose lasts longer: Thinking of fat as a reservoir that slowly empties is an intuitive picture. Volume capacity is not what sets the speed, and subcutaneous doses are generally smaller than intramuscular ones rather than larger.

Fat sits closer to the lymph vessels that carry the drug: Lymphatic uptake is a real mechanism for a few drug types, so it sounds credible. The ordinary path out of subcutaneous tissue is the local blood supply, and it is the low blood flow there that slows things down.

Fat is less sensitive, so a larger needle can be used: Comfort does differ between sites, which makes this feel practical. Needle size is not what the route is chosen for, and subcutaneous injections use a shorter, finer needle rather than a larger one.

Raise the bag higher to increase the gravity head: Raising the bag is the first thing anyone does when a drip runs slowly, and with a vein it often works. The marrow will not run by gravity at any bag height, so this costs time during an arrest and changes nothing.

Pull the needle back slightly and reconnect the tubing firmly: A mechanical problem at the hub is a reasonable thing to suspect when nothing moves. Backing the needle out risks pulling it out of the marrow space entirely, and the far more likely reason nothing is flowing is that it has not been flushed.

Replace the needle at the proximal humerus site: Moving to the humerus is a legitimate choice when a site has genuinely failed, and it does give higher flow in an adult. This site has not been shown to fail yet, and abandoning a correctly placed needle mid arrest wastes the access you already have.

Decline the order because the patient has no prescription for that drug: The prescription question is a real distinction elsewhere, since assisting with a patient's own medication differs from administering a service-stocked one. It is not what fails here. A service may give its own stocked nitroglycerin to a patient who has no prescription at all. The reason this order fails is the route rather than whose drug it is, and getting the reason wrong will lead you to comply the next time a prescription exists.

Place the patch, since the order came from a physician: A physician order carries real authority, and deferring to it feels both respectful and safe. Medical direction can direct care within your certified scope, but it cannot expand that scope, so an order does not make a Paramedic-level route legal for you.

Place the patch and record the physician's name in the report: Documenting who gave the order looks like it protects everyone involved. Recording the name does not change what you are permitted to do, and a well documented out-of-scope act is still an out-of-scope act.

Right patient: the check that fails when the correct dose of the correct drug reaches the wrong person, or a patient with a documented allergy or contraindication to it. Nothing in this question concerns who received the medication. The described failure is arithmetic between the label and the syringe, which is a different question entirely: right patient asks who, right dose asks how much.

Right route: the check that catches a preparation intended for one route given by another, such as an intramuscular dose pushed intravenously, and it matters because the route governs how fast and how completely a drug reaches circulation. The question never says the route was wrong. It says the labeled concentration was never checked against the calculated amount, which is a quantity problem rather than a delivery-path problem.

Right documentation: the check that fails when the drug, dose, route, time, and the patient's response never make it onto the chart. It happens after the medication is given, and this error occurred before it. Documentation would have recorded this dose faithfully too, a wrong one, written down accurately.

Subcutaneous tissue is located closer to major blood vessels: This gets the anatomy backwards: subcutaneous tissue sits above muscle, not closer to major vessels, and its poor perfusion is exactly why absorption from that layer is slow. It answers a proximity question the option itself invents rather than the blood flow difference the question is testing.

Intramuscular injections use a shallower needle angle than subcutaneous injections: Needle angle is real, but it's reversed here: IM injections use a steep angle, close to 90 degrees, to drive the needle through fat into muscle, while SC injections use a shallow angle, around 45 degrees, into a pinched skin fold. Angle affects where the drug lands, not why muscle absorbs it faster once it's there.

Subcutaneous injections bypass first-pass liver metabolism: First-pass metabolism describes drug bypassing the liver via routes like sublingual or IV, not a factor that distinguishes IM from SC. Both IM and SC drugs still enter venous circulation and pass through the liver, so this mechanism doesn't apply to either route.